Search Results

There are 21445 results for: content related to: Prospective evaluation of faecal neutrophil-derived proteins in identifying intestinal inflammation: combination of parameters does not improve diagnostic accuracy of calprotectin

  1. Role of fecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel disease

    Inflammatory Bowel Diseases

    Volume 12, Issue 6, June 2006, Pages: 524–534, Michael R. Konikoff and Lee A. Denson

    Version of Record online : 14 DEC 2006, DOI: 10.1097/00054725-200606000-00013

  2. High level of fecal calprotectin at age 2 months as a marker of intestinal inflammation predicts atopic dermatitis and asthma by age 6

    Clinical & Experimental Allergy

    Volume 45, Issue 5, May 2015, Pages: 928–939, L. Orivuori, K. Mustonen, M. C. de Goffau, S. Hakala, M. Paasela, C. Roduit, J.-C. Dalphin, J. Genuneit, R. Lauener, J. Riedler, J. Weber, E. von Mutius, J. Pekkanen, H. J. M. Harmsen, O. Vaarala and the PASTURE Study Group

    Version of Record online : 16 APR 2015, DOI: 10.1111/cea.12522

  3. You have free access to this content
    Faecal calprotectin: a biomarker of gastrointestinal disease in systemic sclerosis

    Journal of Internal Medicine

    Volume 270, Issue 1, July 2011, Pages: 50–57, K. Andréasson, A. Scheja, T. Saxne, B. Ohlsson and R. Hesselstrand

    Version of Record online : 9 JAN 2011, DOI: 10.1111/j.1365-2796.2010.02340.x

  4. Calprotectin Induces IL-6 and MCP-1 Production via Toll-Like Receptor 4 Signaling in Human Gingival Fibroblasts

    Journal of Cellular Physiology

    Volume 232, Issue 7, July 2017, Pages: 1862–1871, Yasufumi Nishikawa, Yukari Kajiura, Jung Hwan Lew, Jun-ichi Kido, Toshihiko Nagata and Koji Naruishi

    Version of Record online : 6 JAN 2017, DOI: 10.1002/jcp.25724

  5. You have free access to this content
    Calprotectin is released from human skeletal muscle tissue during exercise

    The Journal of Physiology

    Volume 586, Issue 14, July 2008, Pages: 3551–3562, Ole Hartvig Mortensen, Kasper Andersen, Christian Fischer, Anders Rinnov Nielsen, Søren Nielsen, Thorbjörn Åkerström, Maj-brit Aastrøm, Rehannah Borup and Bente Klarlund Pedersen

    Version of Record online : 14 JUL 2008, DOI: 10.1113/jphysiol.2008.153551

  6. Induction of calprotectin release by Porphyromonasgingivalis lipopolysaccharide in human neutrophils

    Oral Microbiology and Immunology

    Volume 19, Issue 3, June 2004, Pages: 182–187, J. Kido, R. Kido, Suryono, M. Kataoka, M. K. Fagerhol and T. Nagata

    Version of Record online : 26 APR 2004, DOI: 10.1111/j.0902-0055.2004.00139.x

  7. Effects of calprotectin in avridine-induced arthritis


    Volume 103, Issue 1-6, January 1995, Pages: 233–240, JOHAN G. Brun, GEIR HÅLand, HANS-JACOB Haga, MAGNE K. Fagerhol and ROLAND Jonsson

    Version of Record online : 15 AUG 2009, DOI: 10.1111/j.1699-0463.1995.tb01100.x

  8. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease

    Inflammatory Bowel Diseases

    Volume 18, Issue 12, December 2012, Pages: 2218–2224, Geert D'Haens, Marc Ferrante, Severine Vermeire, Filip Baert, Maja Noman, Liesbeth Moortgat, Patricia Geens, Doreen Iwens, Isolde Aerden, Gert Van Assche, Gust Van Olmen and Paul Rutgeerts

    Version of Record online : 16 FEB 2012, DOI: 10.1002/ibd.22917

  9. Effects of Human Calprotectin (L1) on In Vitro Immunoglobulin Synthesis

    Scandinavian Journal of Immunology

    Volume 40, Issue 6, December 1994, Pages: 675–680, J. G. BRUN, E. ULVESTAD, M. K. FAGERHOL and R. JONSSON

    Version of Record online : 29 JUN 2006, DOI: 10.1111/j.1365-3083.1994.tb03523.x

  10. Plasma Calprotectin Predicts Mortality in Patients with ST Segment Elevation Myocardial Infarction Treated with Primary Percutaneous Coronary Intervention

    Journal of Interventional Cardiology


    Version of Record online : 12 MAR 2010, DOI: 10.1111/j.1540-8183.2010.00532.x

  11. Role of fecal calprotectin testing to predict relapse in teenagers with inflammatory bowel disease who report full disease control

    Inflammatory Bowel Diseases

    Volume 18, Issue 11, November 2012, Pages: 2018–2025, Patrick F. van Rheenen

    Version of Record online : 24 JAN 2012, DOI: 10.1002/ibd.22896

  12. You have free access to this content
    Kinetical Analysis of Tumor Cell Death-Inducing Mechanism by Polymorphonuclear Leukocyte-Derived Calprotectin: Involvement of Protein Synthesis and Generation of Reactive Oxygen Species in Target Cells

    Microbiology and Immunology

    Volume 42, Issue 3, March 1998, Pages: 211–221, Masaaki Mikami, Masatoshi Yamazaki and Satoru Yui

    Version of Record online : 14 NOV 2013, DOI: 10.1111/j.1348-0421.1998.tb02273.x

  13. You have free access to this content
    Anti-Candida Activity of Cal protect in in Combination with Neutrophils or Lactoferrin

    Microbiology and Immunology

    Volume 42, Issue 11, November 1998, Pages: 789–793, Takafumi Okutomi, Takashi Tanaka, Satoru Yui, Masaaki Mikami, Masatoshi Yamazaki, Shigeru Abe and Hideyo Yamaguchi

    Version of Record online : 14 NOV 2013, DOI: 10.1111/j.1348-0421.1998.tb02353.x

  14. Proinflammatory cytokines upregulate expression of calprotectin (L1 protein, MRP-8/MRP-14) in cultured human keratinocytes

    British Journal of Dermatology

    Volume 149, Issue 3, September 2003, Pages: 484–491, G. Mørk, H. Schjerven, L. Mangschau, E. Søyland and P. Brandtzaeg

    Version of Record online : 23 SEP 2003, DOI: 10.1046/j.1365-2133.2003.05536.x

  15. Calprotectin levels in gingival crevicular fluid predict disease activity in patients treated for generalized aggressive periodontitis

    Journal of Periodontal Research

    Volume 46, Issue 4, August 2011, Pages: 417–426, D. Kaner, J.-P. Bernimoulin, T. Dietrich, B.-M. Kleber and A. Friedmann

    Version of Record online : 13 APR 2011, DOI: 10.1111/j.1600-0765.2011.01355.x

  16. Salivary calprotectin levels are raised in patients with oral candidiasis or Sjögren’s syndrome but decreased by HIV infection

    Oral Microbiology and Immunology

    Volume 16, Issue 2, April 2001, Pages: 119–123, S. P. Sweet, A. N. Denbury and S. J. Challacombe

    Version of Record online : 21 DEC 2001, DOI: 10.1034/j.1399-302x.2001.016002119.x

  17. Serum Calprotectin Versus Acute-Phase Reactants in the Discrimination of Inflammatory Disease Activity in Rheumatoid Arthritis Patients Receiving Tumor Necrosis Factor Inhibitors

    Arthritis Care & Research

    Volume 68, Issue 7, July 2016, Pages: 899–906, José Inciarte-Mundo, Maria Victoria Hernández, Virginia Ruiz-Esquide, Sonia Raquel Cabrera-Villalba, Julio Ramirez, Andrea Cuervo, Mariona Pascal, Jordi Yagüe, Juan D. Cañete and Raimon Sanmarti

    Version of Record online : 23 JUN 2016, DOI: 10.1002/acr.22795

    Corrected by:

    Erratum: Incorrect Value in Table 2 in the Article by Inciarte-Mundo et al (Arthritis Care Res [Hoboken], July 2016)

    Vol. 69, Issue 1, 155, Version of Record online: 27 DEC 2016

  18. Plasma calprotectin: A new prognostic marker of survival in alcohol-induced cirrhosis


    Volume 21, Issue 4, April 1995, Pages: 979–985, Christian Homann, Peter Garred, Niels Graudal, Philip Hasselqvist, Michael Christiansen, Magne K. Fagerhol and Åge Christian Thomsen

    Version of Record online : 9 DEC 2005, DOI: 10.1002/hep.1840210415

  19. Detection of calprotectin and its correlation to the accumulation of neutrophils within equine large colon during ischaemia and reperfusion

    Equine Veterinary Journal

    Volume 40, Issue 4, June 2008, Pages: 393–399, A. GROSCHEt, A. J. MORTON, M. M. R. POLYAK, S. MATYJASZEK and D. E. FREEMAN

    Version of Record online : 5 JAN 2010, DOI: 10.2746/042516408X302500

  20. The prognostic significance of faecal calprotectin in patients with inactive inflammatory bowel disease

    Alimentary Pharmacology & Therapeutics

    Volume 44, Issue 5, September 2016, Pages: 495–504, Y. Zhulina, Y. Cao, K. Amcoff, M. Carlson, C. Tysk and J. Halfvarson

    Version of Record online : 12 JUL 2016, DOI: 10.1111/apt.13731